SEC Form 4 · accession 0001062993-16-006987
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Wegman
Officer — President · Director · 10% Owner
Period of report
Jan 11, 2016
Accepted (ET)
Jan 11, 2016 · 10:53 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Jan 11, 2016 | M | 100,000 | $1.00 | A | 220,822 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.00 | Jan 11, 2016 | M | 100,000 | D | Jan 23, 2006 | Jan 23, 2016 | Common Stock, $0.001 par value | 100,000 | 0 | D |
Explanation of responses
- F1The option was granted on January 23, 2006 and vested immediately. All shares underlying the option have vested.